The changes in CD133+ cells before and after RNAi regarding the CD133 mRNA and protein expression levels, abilities of proliferation, clone sphere formation and in vivo tumor formation, resistance to the chemotherapy drug, and invasion ability as well as invasion-related factors were detected. The gene discussed is PROM1; the disease is neoplasm.